Relmada Therapeutics, Inc. RLMD Basis differences on investments
Basis differences on investments at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s basis differences on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s basis differences on investments?
- Relmada Therapeutics, Inc. (RLMD) reported basis differences on investments of $7.76M in Q4 2024.
- What does basis differences on investments mean?
- The tax benefit associated with unrealized losses on investment securities that are expected to be recovered in future periods. This asset reflects the difference between the book value and tax basis of investments, often arising from market fluctuations. It is a critical component for understanding the company's deferred tax position and potential future tax savings.